These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22784637)

  • 1. Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature.
    Gregson J; Stirnadel-Farrant HA; Doobaree IU; Koro C
    Atherosclerosis; 2012 Nov; 225(1):11-21. PubMed ID: 22784637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].
    Jia ZR; Zhao D; Qi Y; Wang W; Wang M; Sun JY; Qin LP; Liu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):962-7. PubMed ID: 24370228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of lipoprotein-associated phospholipase A₂ activity with components of the metabolic syndrome in apparently healthy boys.
    Hirschler V; Meroño T; Maccallini G; Gomez Rosso L; Aranda C; Brites F
    Cardiovasc Hematol Agents Med Chem; 2011 Apr; 9(2):78-83. PubMed ID: 21476960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.
    Onat A; Hergenç G; Can G; Uğur M; Nartop F
    Clin Chem Lab Med; 2011 Aug; 49(8):1349-1357. PubMed ID: 21756164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.
    Enkhmaa B; Anuurad E; Zhang W; Pearson TA; Berglund L
    Atherosclerosis; 2010 Aug; 211(2):526-30. PubMed ID: 20444451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.
    Tehrani DM; Gardin JM; Yanez D; Hirsch CH; Lloyd-Jones DM; Stein PK; Wong ND
    Atherosclerosis; 2013 Dec; 231(2):246-51. PubMed ID: 24267235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
    Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM
    J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.
    Anuurad E; Ozturk Z; Enkhmaa B; Pearson TA; Berglund L
    J Clin Endocrinol Metab; 2010 May; 95(5):2376-83. PubMed ID: 20194707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationships among platelet-activating factor and lipoprotein-associated phospholipase A
    English CJ; Lohning AE; Mayr HL; Jones M; Reidlinger DP
    Biofactors; 2023 Mar; 49(2):457-471. PubMed ID: 36538603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial variation in lipoprotein-associated phospholipase A₂ in older adults.
    Lee KK; Fortmann SP; Varady A; Fair JM; Go AS; Quertermous T; Hlatky MA; Iribarren C
    BMC Cardiovasc Disord; 2011 Jun; 11():38. PubMed ID: 21714927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.
    Gungor Z; Anuurad E; Enkhmaa B; Zhang W; Kim K; Berglund L
    Atherosclerosis; 2012 Jul; 223(1):230-4. PubMed ID: 22632920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A₂ activity and mass in relation to vascular disease and nonvascular mortality.
    Heart Protection Study Collaborative Group
    J Intern Med; 2010 Oct; 268(4):348-58. PubMed ID: 21050287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.
    Ridker PM; MacFadyen JG; Wolfert RL; Koenig W
    Clin Chem; 2012 May; 58(5):877-86. PubMed ID: 22419750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
    Noto H; Chitkara P; Raskin P
    J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study.
    da Silva IT; Timm Ade S; Damasceno NR
    Lipids Health Dis; 2013 Feb; 12():19. PubMed ID: 23413990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study.
    Nelson TL; Kamineni A; Psaty B; Cushman M; Jenny NS; Hokanson J; Furberg C; Mukamal KJ
    Diabetologia; 2011 Feb; 54(2):329-33. PubMed ID: 21103980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study.
    Tselepis AD; Panagiotakos DB; Pitsavos C; Tellis CC; Chrysohoou C; Stefanadis C
    Atherosclerosis; 2009 Sep; 206(1):303-8. PubMed ID: 19394616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.
    Madjid M; Ali M; Willerson JT
    Tex Heart Inst J; 2010; 37(1):25-39. PubMed ID: 20200624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.